Blog

• Earlier this week, China formally restricted rare earth element exports and imposed sanctions on certain shipping companies, heightening global trade tensions and disrupting critical mineral flows.

• Energy Fuels stands out with its U.S.-based rare earth assets and capabilities, drawing heightened attention as governments seek to strengthen domestic supply chains and reduce reliance on Chinese exports.

• We’ll examine how Energy Fuels’ role as a U.S. rare earth supplier amid rising U.S.-China tensions could influence its investment outlook.

The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer’s.

To own shares of Energy Fuels, an investor must see value in its ambition to become a leading U.S.-based supplier of rare earth oxides and uranium as Western countries prioritize secure critical mineral supply chains. While China’s new export restrictions have driven short-term interest, the most immediate catalyst for the stock remains execution on rare earth production expansion at White Mesa. The biggest risk is still the company’s heavy reliance on third-party feedstock and uncertainty around advancing its own mining projects; this news does not immediately resolve supply chain challenges.

One recent announcement directly tied to this theme is Energy Fuels’ qualification of high-purity neodymium-praseodymium oxide for use in electric vehicle motors, achieved at its White Mesa Mill. As Western automakers and governments seek alternatives to Chinese materials, achieving this production milestone could support Energy Fuels’ push to gain offtake deals or policy support, both of which are central to unlocking further upside.

By contrast, investors should be aware that Energy Fuels’ rare earth business still faces supply bottlenecks of its own, with no guaranteed feedstock from its early-stage projects and…

Read the full narrative on Energy Fuels (it’s free!)

Energy Fuels’ narrative projects $553.4 million revenue and $237.8 million earnings by 2028. This requires 104.1% yearly revenue growth and a $330.9 million earnings increase from -$93.1 million.

Uncover how Energy Fuels’ forecasts yield a CA$22.35 fair value, a 24% downside to its current price.

Eleven Simply Wall St Community members estimate Energy Fuels’ fair value anywhere from US$2.73 to US$146.07, showing a remarkable breadth of outlooks. Amid these wide-ranging opinions, the company’s success may hinge on resolving rare earth feedstock constraints in light of tighter global trade conditions, so consider all viewpoints before forming your own.

Explore 11 other fair value estimates on Energy Fuels – why the stock might be worth less than half the current price!

Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.

The market won’t wait. These fast-moving stocks are hot now. Grab the list before they run:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include EFR.TO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

• In the past week, Robert Half was recognized by Forbes as one of the World’s Best Employers for 2025, an accolade based on an independent survey of more than 300,000 employees across 50 countries that measures satisfaction, culture, and global reputation.

• This global recognition underscores Robert Half’s continued investment in employee well-being and its reputation as an employer committed to professional and personal growth opportunities.

• We’ll examine how Robert Half’s global employer recognition could shape its investment narrative by highlighting employee-focused strengths and culture.

Trump has pledged to “unleash” American oil and gas and these 22 US stocks have developments that are poised to benefit.

To be a shareholder in Robert Half today, you have to believe that its reputation as a top global employer translates into long-term competitive advantages, especially as the biggest short-term catalyst remains a sustained recovery in hiring demand, while persistent pressures on revenue and margin are still the biggest risks. The recent Forbes World’s Best Employers award is a boost for the company’s employer brand, but it is unlikely to materially shift the near-term outlook given ongoing headwinds in the core business.

Among recent announcements, Robert Half continues consistent quarterly dividends, with the most recent payout of US$0.59 per share, reinforcing its focus on rewarding shareholders, even through a period of weak revenue trends. This dividend consistency may offer reassurance for some investors as they weigh the potential impact of new accolades on the company’s fundamental recovery story.

In contrast, investors should be aware of persistent revenue declines and the risk that…

Read the full narrative on Robert Half (it’s free!)

Robert Half’s narrative projects $5.9 billion in revenue and $313.2 million in earnings by 2028. This requires 1.9% annual revenue growth and a $135.1 million increase in earnings from $178.1 million today.

Uncover how Robert Half’s forecasts yield a $41.56 fair value, a 33% upside to its current price.

Five fair value estimates from the Simply Wall St Community range from US$32 to US$49,991.88, reflecting strikingly wide opinions on Robert Half’s potential. While investor confidence varies, the ongoing risk of flat or declining sales continues to be a factor in shaping expectations for the business’s trajectory, consider exploring several viewpoints before drawing your own conclusion.

Explore 5 other fair value estimates on Robert Half – why the stock might be a potential multi-bagger!

Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.

Right now could be the best entry point. These picks are fresh from our daily scans. Don’t delay:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include RHI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

An “exciting milestone” has been reached in the development of a new medical testing centre set to open this year.

All 13 modular units which will make up the building of the community diagnostic centre at the Camborne Redruth Community Hospital have been delivered and connected.

NHS Cornwall and Isles of Scilly said internal work was now underway to complete the fit-out ahead of the facility opening to patients.

Susan Bracefield, chief nursing officer of NHS Cornwall, said: “We are excited to be opening another new community diagnostic centre for Cornwall, as part of our continued investment in delivering more services closer to people’s homes, something we know local people really value.”

She added the centre would mean more patients would benefit from faster diagnosis, shorter waiting times, and improved access to treatment.

Once operational the community diagnostic centre would provide:

• X-rays, MRI and CT scans
• Blood tests (phlebotomy)
• ECGs and respiratory checks
• Endoscopy services

Geoff Searle, chief executive of InHealth, added: “This is an exciting milestone in the South West CDC programme.

“Expanding this model of healthcare in the South West will bring real benefits to local patients, improving health outcomes through greater access, capacity and choice.”

NHS Cornwall said the hospital site already had strong public transport links but would see an additional 22 new parking bays to ensure easy and convenient access for patients and visitors.